Blood levels of cardiac troponin I in the elderly women with and without dementia

Sabaheta Hasić, Lejla Redžić, Nina Čamdžić, Emina Spahic, Orhan Lepara, Emina Kiseljaković, Radivoj Jadrić


Objectives: We hypothesized that cardiac biomarker levels could be elevated in patients with dementia due to high frequency of cardiovascular risk factors in older patients with vascular and neurodegenerative type of this disease. The aim was to determine possible association between cardiac Troponin I (cTnI) blood levels and dementia.

Methods: The cross-sectional study included 88 patients, female gender, and mean age 81 years, who were recruited from specialized unit of the Health Care Hospice for persons with disabilities in Sarajevo, Bosnia and Herzegovina. According to the Hachinski ischemic score, 59 patients with dementia were classified in two groups- vascular (VD) and neurodegenerative dementia (ND), while 29, age-matched asymptomatic persons, were used as a control group(CG). The cTnI was measured using ELISA kit Humani Tn-I/TNNI3 (Elabscience Biotechnology Co., Ltd), using immunoanalayzer STAT FAX 2100, USA.

Results:The Mini-Mental State Examination (MMSE)score was significantly lower in dementia patients than in control group (p<0.01). No significant difference in cardiac TnI levels was found in Alzheimer’s (AD), vascular dementia (VD)  and control group (AD: Me = 3.41, VD: Me = 3.49, control group: Me=3.57; (p=0.737).

Conclusion:The participants’age and comorbidities are probable factors causing no association between dementia and cTnI. It is known that troponins are associated with risk of dementia but cTnI levels are as well under influences of a possible epigenetic modification of cTnI that should be the objects of the future investigation. 

Full Text:



American Psychiatric Association.Diagnostic and Statistical Manual of Mental Disorders (5th edition). Arlington, Va.: American Psychiatric Publishing; 2013.

Wiesmann M, Kiliaan AJ, Claassen JA.Vascular aspects of cognitive impairment and dementia.J Cereb Blood Flow Metab.2013; 33:1696-1706.

Duron E, Hanon O. Vascular risk factors, cognitive decline, and dementia Vasc Health Risk Manag. 2008; 4(2): 363–381.

Viswanathan A, Rocca WA, Tzourio C. Vascular risk factor and dementia. Neurology. 2009;72(4):368–374.

Heckman GA, Patterson CJ, Demers C, Onge JS, Turpie ID, McKelvie RS. Heart failure and cognitive impairment: challenges and opportunities.Clin Interv Aging. 2007;2(2):209–218.

Schneider ALC, Rawlings AM, Sharret AR, Alonso A, Mosley TH, Hoogeveen RC, et al. High-sensitivity cardiac troponin T and cognitive function and dementia risk: the atherosclerosis risk in communities study. Eur Heart J. 2014;35:1817-1824.

McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984; 34(7):939–944.

Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993; 43(2):250-60.

Folstein MF, Folstein SE, McHugh PR.Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3):189-98.

Launer LJ. Overview of incidence studies of dementia conducted in Europe. Neuroepidemiology. 1992; 11 Suppl 1:2-13.

Talaat FM, Zaki MA , El-Rahman AA, El-Sayed MA, Fathy S, Hassan R, et al. Neuropsychiatric Assessment of Vascular Dementia. Egypt J Neurol Psychiat Neurosurg. 2006; 43(2):409–422.

Daubert MA, Jeremias A. The utility of troponin measurement to detect myocardial infarction. Vascular Health and Risk Management. 2010; 6:691-699.

Christian H.N, Matthias E. The heart of the matter: a link between troponin and dementia. Eur Heart J. 2014; 35(27):1779-1781.

Venge P, Johnston N, Lagerqvist B, Wallentin L, Lindahl B.Clinical and analytical performance of the liaison cardiac troponin I assay in unstable coronary artery disease, and the impact of age on the definition of reference limits.Clin Chem. 2003;49(6 Pt 1):880-886.

Kuster N, Monnier K, Baptista G, Dupuy AM, Badiou S, Bargnoux AS, et al. Estimation of age and comorbidities-adjusted percentiles of high-sensitivity cardiac troponin T levels in the elderly. Clin Chem Lab Med. 2015; 53(5): 691-98.

Masson S., Latini R, Mureddu G, Agabiti N, Miceli M, Cesaroni G, et al. High sensitivity cardiac troponin T for detection of subtle abnormalities of cardiac phenotype in a general population of elderly individuals. J Intern Med.2013;273: 306–17.

Myint PK, Kwok CS, Bachmann MO, Stirling S, Shepstone L, Zaman MJ. Prognostic value of troponins in acute coronary syndrome depends upon patient age. Heart. 2014; 100:1583-90.

Pan B, Xu ZW, Xu Y, Liu LJ, Zhu J, Wang X, et al. Diastolic dysfunction and cardiac troponin I decrease in aging hearts. Arch Biochem Biophys. 2016;603:20-8.

Hilal S, Chai YL, Ikram MK, Elangovan S, Yeow TB, Xin X, et al. Markers of Cardiac Dysfunction in Cognitive Impairment and Dementia. Medicine (Baltimore). 2015;94(1):e297.


  • There are currently no refbacks.